| GB0111872D0 (en) | | Therapeutic agents and methods |
| EP1372739A4 (en) | | Stabilized therapeutic and imaging agents |
| AU2003213997A1 (en) | | Biologically active copper-organic agents |
| GB0105613D0 (en) | | Pharmaceutically effective compounds and their use |
| IL146795A0 (en) | | Biologically active materials |
| EP1511753A4 (en) | | Antimicrobial agents and uses thereof |
| GB0205347D0 (en) | | Biologically active complex |
| AU6269901A (en) | | Biologically active agents and drugs |
| AU2002343197A8 (en) | | Biologically active complex |
| AU2001262699A1 (en) | | Biologically active agents and drugs |
| GB0018887D0 (en) | | Compound and their therapeutic use |
| GB0119981D0 (en) | | Biologically and therapeutically active agents |
| GB0119264D0 (en) | | Biologically and therapeutically active agents |
| GB0103354D0 (en) | | Biologically active agents |
| GB0019101D0 (en) | | Biologically and therapeutically active agents |
| GB0019100D0 (en) | | Biologically and therapeutically active agents |
| GB0219029D0 (en) | | Biologically and therapeutically active agents |
| GB0219031D0 (en) | | Biologically and therapeutically active agents |
| GB0119244D0 (en) | | Biologically and therapeutically active agents against HIV-1 |
| AU2002229932A1 (en) | | Delivery of biologically active agents |
| GB9915380D0 (en) | | Biologically and therapeutically active agents |
| GB0306345D0 (en) | | Biologically and therapeutically active agents |
| GB0305644D0 (en) | | Biologically and therapeutically active agents |
| GB0019096D0 (en) | | Biologically and therapeutically active agents against HIV-1 |
| GB0218483D0 (en) | | Biologically and therapeutically active agents against HIV-1 |